Skip to main content

BIOPTIK 4161

Close 20.9 ▼ 0.2 (−0.95%)
End-of-day data, not real-time quotes
Four-Light Health Check
Overall score 53/ 100
Average −10 vs. yesterday
  • 📈 Fundamentals 🔴 Weak Yesterday 🟡 → Today 🔴 ↓ Weakened
  • 👁 Flows 🟡 Neutral Same as yesterday
  • 📊 Technicals 🟡 Neutral Same as yesterday
  • 💰 Valuation 🟢 Strong Same as yesterday
💡 Worth noting today
  • Health Health check: Fundamentals light changed from yellow to red bearish New
  • Technical Closed below the 20-day MA today (close 20.90 / MA20 21.06) bearish New
  • Health Overall health score down 10 points vs. yesterday bearish
  • Valuation P/E of 11.7x sits in the historically cheap band bullish
Health check

BIOPTIK (4161) Four-Light Health Check

Loading…

💡 In one line: ()

Weighting:📈 Fundamentals %|👁 Flows %|📊 Technical %|💰 Valuation %

BIOPTIK (4161)

Overall health score / 100

weight %

→
Four-light detail
  • 📈 Fundamentals -
  • 👁 Flows -
  • 📊 Technicals -
  • 💰 Valuation -
The underlying four-light factors are VIP content

VIP shows the actual value, rule and note of every factor, with no daily limit.

VIP unlocks
  • Unlimited access to the factors and rules behind every stock/ETF four-light health check
  • P/E and P/B valuation river charts
  • Full sector health rankings and relative positioning
  • Post-close LINE alerts for your watchlist
For more filters, go to Smart Screener

Data as of: |This site is not a licensed securities investment consultancy. The four lights are a statistical summary of public information and do not constitute investment advice.

BIOPTIK (4161) Technical indicators

End-of-day data, not real-time quotes
  • Open 21.25
  • High 21.3
  • Low 20.9
  • Close 20.9
  • Volume 9
  • Prev close 21.1

BIOPTIK (4161) today trades above the 5-day MA but still below the 20-day (monthly) MA and 60-day (quarterly) MA, losing the 20-day (monthly) MA today. MACD keeps a positive histogram that is still widening, KD sits at 55 in neutral territory, RSI is 43 with soft short-term momentum.

Signals today

  • ● The price lost the 20-day (monthly) MA today
  • ● MACD keeps a positive histogram

Indicator values

Item Value
Close 20.90
5-day MA 20.86
20-day (monthly) MA 21.06
60-day (quarterly) MA 21.93
120-day (half-yearly) MA 22.41
240-day (yearly) MA 23.80
K (9) 54.76
D (9) 42.59
RSI (14) 42.79
Bollinger upper band (20) 21.65
Bollinger lower band (20) 20.46
DIF (12,26) -0.26
MACD (9) -0.29
OSC histogram 0.04
Volume (lots) 9
20-day avg. volume (lots) 25
Volume ratio (volume ÷ 20-day avg.) 0.36
Indicator

BIOPTIK (4161) Monthly revenue

Latest revenue for 10/2026 was NT$48.14M, MoM +0.95%, YoY -20.32%.
Cumulative revenue through 10/2026 was NT$704.06M, cumulative YoY +6.39%.
Full-year 2025 revenue was NT$837.19M.
Month Close Revenue (NT$M) MoM change YoY change YTD vs. same period last year
Month Close Revenue (NT$M) MoM change YoY change YTD vs. same period last year
A professional algo-trading development team at your service
Algo-trading development

BIOPTIK (4161) EPS

Latest EPS for Q3 2026 was NT$0.32, QoQ -52%, YoY -22%.
Cumulative EPS through Q3 2026 was NT$1.28, YoY +64%.
Full-year 2025 EPS was NT$1.23.

Income statement

Year / quarter Close Revenue (NT$M) Gross profit Operating income Net income EPS

BIOPTIK (4161) Profitability

ROE / ROA (%)

Year / quarter Close Quarterly ROE Trailing 4Q ROE Quarterly ROA Trailing 4Q ROA

BIOPTIK (4161) — is it a buy?

P/E river chart

The P/E river chart is a valuation tool best suited to companies with stable earnings.

Rising river: earnings power is steadily improving.
Flat river: earnings power is relatively stable.
Falling river: earnings power is deteriorating.

The chart splits P/E into three bands: red, yellow and blue.
The current price sits in the blue band, meaning the share price is at a relatively low level
The P/E river chart is VIP content

Unlock to see the last 5 years of the P/E river chart

VIP unlocks
  • Unlimited access to the factors and rules behind every stock/ETF four-light health check
  • P/E and P/B valuation river charts
  • Full sector health rankings and relative positioning
  • Post-close LINE alerts for your watchlist

P/B river chart

The P/B river chart is a valuation tool best suited to companies with unstable earnings, such as cyclicals.

Rising river: book value is steadily improving.
Flat river: book value is relatively stable.
Falling river: book value is deteriorating.

The chart splits P/B into three bands: red, yellow and blue.
Based on the latest book value, the current price sits in the blue band, meaning the share price is at a relatively low level.
The P/B river chart is VIP content

Unlock to see the last 5 years of the P/B river chart

VIP unlocks
  • Unlimited access to the factors and rules behind every stock/ETF four-light health check
  • P/E and P/B valuation river charts
  • Full sector health rankings and relative positioning
  • Post-close LINE alerts for your watchlist

BIOPTIK (4161) Dividend policy

The latest ex-dividend date was 2026/07/16, distribution No.1 of 2026, paying a cash dividend of NT$0.7, a cash yield of 3.03%.
Over the past five years the average cash dividend was NT$0.4, for an average cash yield of 1.45%.
Year Ex-date Price before ex-date Cash dividend Payment date Cash yield Stock dividend

BIOPTIK (4161) Institutional flows, margin & short

Date Foreign Inv. Trust Dealer Total
Date Margin balance (lots) Short balance (lots) Short/margin ratio (%)

sector ranking

Ticker Health score Close Change Volume Turnover (100M)

()
(this stock)

BIOPTIK (4161) — what it does

BIOPTIK (4161) full name: BIOPTIK, in the 生技醫療業 sector, with paid-in capital of 5.98 億 and a market cap of 12.50 億.
Founded on 1999/06/01, listed on the TPEx on 2013/06/26,
its principal business is 居家醫療檢測產品、生醫材料及產品、天然蝦紅素及原料.

Company BIOPTIK Website
Chairman 楊金昌 President 涂耀仁
Founded 1999/06/01 TPEx listing date 2013/06/26
Industry 生技醫療業 Business tax ID 16930971
Address 350苗栗縣竹南鎮公館里中華南路188號
Main business 居家醫療檢測產品、生醫材料及產品、天然蝦紅素及原料
Paid-in capital 5.98 億
Ordinary shares issued 5,979.82 萬 shares
Market cap 12.50 億 (2026/11/12)
Preferred shares 0 shares
Auditor 資誠聯合會計師事務所
Transfer agent 群益金鼎證券股份有限公司

Recommended brokerage accounts

如果想要開戶,目前新光證券的開戶好禮最多,新戶贈送證券期貨手續費折抵金 3000 元

也可以參考 Win投資證券開戶彙整 ,有更簡潔完善的資訊分享,包含特色、開戶禮等。

名稱台股手續費新戶禮
新光證券
(開戶點我)
手續費 0 元
每月電子下單 100 萬以內
  • 享手續費折扣優惠 + $3,000 以上手續費抵用金
  • 定期定額年年有獎勵,500元真優惠
  • 開戶次月底前下單再送10000元新光幣/LINE POINTS等好禮
  • 立即體驗富貴角 XQ 下單系統,專業功能全免費
  • 2026/1/1 ~ 2026/12/31
玉山證券
(開戶點我)
2026 年 10 月起調降手續費率超低優惠。
詳 官網

新戶禮 $108 手續費回饋金

活動日期到 2027/9/30

國泰證券
(開戶點我)
最低手續費 1 元

完成體驗登記+首筆成交回饋 300 元7-11數位商品卡券

2026/1/1~2026/12/31

口袋證券
(開戶點我)
優惠價查詢

開立台股或台+美股送 $300 手續費折抵金

2026/10/1~12/31

(資料來源:各券商,最新資訊以各券商為主。資料整理:Win 投資)

My Watchlist

Sign in to build and track your own watchlist. Once you add symbols, you get a full closing report every day: health check, technical changes and a comparison against the TAIEX.

Popular News

Popular Articles

🤖 New: AI Investment Assistant (answers in Chinese). Chat to look up Taiwan stocks and ETFs, with tables and charts [👉 Try it free]
Out of free views? VIP gets four-light health checks on any stock and unlimited Smart Screener runs [👉 Unlock now]